Community Pharmacy Practice in Italy during the COVID-19 (SARS-CoV-2) Pandemic: Regulatory Changes and a Cross-Sectional Analysis of Seroprevalence

Int J Environ Res Public Health. 2021 Feb 26;18(5):2302. doi: 10.3390/ijerph18052302.

Abstract

Pharmacists in the community and the essential requirement to safeguard their own health have become fundamental since the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The aims of this paper were (I) to analyze the directives provided to pharmacists in 2020 regarding preventative safety measures to be adopted; (II) to determine the number of pharmacists who came into contact with SARS-CoV-2 in North-West Italy and relate this to the adopted preventative measures. The first aim was pursued by conducting a bibliographic research, consulting the principal regulatory sources. The second one was achieved with an observational study by administering a questionnaire and performing a serological test. The various protection measures imposed by national and regional legislation were analyzed. Two hundred and eighty-six pharmacists (about 8% of the invited ones) responded to the survey. Ten pharmacists reported a positive result to the serological test. Of the subjects who presented a positive result, three declared that they had not used a hand sanitizer, while two stated that they had not scheduled the cleaning and decontamination of surfaces. Two interviewees had not set up a system of quota restrictions on admissions. In four cases, a certified cleaning company had decontaminated the premises. The results of our study show that during the coronavirus disease 2019 (COVID-19) pandemic, the most pressing challenge for community pharmacists has been the protection of staff and clients inside the pharmacy; the challenge to be faced in the near future will probably be the management of new responsibilities.

Keywords: COVID-19; Italy; SARS-CoV-2; community pharmacies; pharmacists; safety measures; seroprevalence.

Publication types

  • Observational Study

MeSH terms

  • COVID-19 / diagnosis*
  • COVID-19 / prevention & control*
  • Community Pharmacy Services / legislation & jurisprudence
  • Community Pharmacy Services / trends*
  • Cross-Sectional Studies
  • Humans
  • Infection Control / standards*
  • Italy / epidemiology
  • Pandemics
  • Seroepidemiologic Studies